Jump to content
The World News Media

FDA approves Ocaliva for rare, chronic liver disease - FDA.gov


Health and Medicine

Recommended Posts

  • Administrator
images?q=tbn:ANd9GcSOA8ldrNLw7Vpc2-0024r
CNA Finance

FDA approves Ocaliva for rare, chronic liver disease
FDA.gov
On Friday, May 27, the U.S. Food and Drug Administration granted accelerated approval for Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate ...
Why Intercept Pharmaceuticals Inc (ICPT) is an Attractive Acquisition TargetBidness ETC
Intercept Pharmaceuticals (ICPT) Stock: FDA Approves OcalivaCNA Finance (press release)
3 Reasons Goldman Sachs Still Neutral On Intercept PharmaBenzinga
InvestorGuide -Monthly Prescribing Reference (registration) -Proactive Investors USA & Canada -Wall Street 24
all 13 news articles »

Google

Link to comment
Share on other sites


  • Views 380
  • Replies 0
  • Created
  • Last Reply

Top Posters In This Topic

Popular Days

Top Posters In This Topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.